TY - JOUR
T1 - Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome
AU - Rizzo, Manfredi
AU - Giglio, Rosaria Vincenza
AU - Nikolic, Dragana
AU - Montalto, Giuseppe
AU - Patti, Angelo Maria
AU - Vanella, Luca
AU - Katsiki, Niki
AU - Al-Rasadi, Khalid
AU - Banerjee, Yajnavalka
PY - 2015
Y1 - 2015
N2 - The impact of a natural supplement (Kepar; Rikrea, Italy), containing several plant extracts such as curcuma longa, silymarin, guggul, chlorogenic acid, and inulin, was evaluated in 78 patients with metabolic syndrome (MetS; 45 men; age: 62 ± 9 years). Kepar at a dose of 2 pills/d was given for 4 months as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study. Anthropometric variables, plasma lipids, glucose parameters, and oxidative stress were measured at baseline and after 4 months. We found significant reductions in body weight (from 81.1 ± 13.5 to 79.4 ± 12.5 kg, P <.0001), body mass index (from 29.6 [23.7] to 29.3 [21.9] kg/m2, P =.001), and waist circumference (from 105 ± 11 to 102 ± 10 cm, P =.0004) as well as in fasting glucose (from 6.5 [11.7] to 6.4 [7.6] mmol/L, P =.014) and total cholesterol (from 4.8 ± 1.4 to 4.5 ± 1.0 mmol/L, P =.03). No significant changes were found in the other appraised parameters, including oxidative stress. In conclusion, after few months of treatment Kepar seems to exert beneficial effects in patients with MetS. Larger studies with a longer follow-up period are needed to confirm these preliminary findings.
AB - The impact of a natural supplement (Kepar; Rikrea, Italy), containing several plant extracts such as curcuma longa, silymarin, guggul, chlorogenic acid, and inulin, was evaluated in 78 patients with metabolic syndrome (MetS; 45 men; age: 62 ± 9 years). Kepar at a dose of 2 pills/d was given for 4 months as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study. Anthropometric variables, plasma lipids, glucose parameters, and oxidative stress were measured at baseline and after 4 months. We found significant reductions in body weight (from 81.1 ± 13.5 to 79.4 ± 12.5 kg, P <.0001), body mass index (from 29.6 [23.7] to 29.3 [21.9] kg/m2, P =.001), and waist circumference (from 105 ± 11 to 102 ± 10 cm, P =.0004) as well as in fasting glucose (from 6.5 [11.7] to 6.4 [7.6] mmol/L, P =.014) and total cholesterol (from 4.8 ± 1.4 to 4.5 ± 1.0 mmol/L, P =.03). No significant changes were found in the other appraised parameters, including oxidative stress. In conclusion, after few months of treatment Kepar seems to exert beneficial effects in patients with MetS. Larger studies with a longer follow-up period are needed to confirm these preliminary findings.
KW - Medicinal; Silymarin; Time Factors; Treatment Outcome; Weight Loss; Curcuma; Dietary Supplements; Cardiology and Cardiovascular Medicine; Medicine (all)
KW - chlorogenic acid; cholesterol; Curcuma longa; guggul; inulin; metabolic syndrome; natural supplement; oxidative stress; silymarin; Aged; Biomarkers; Blood Glucose; Chlorogenic Acid; Cholesterol; Female; Humans; Inulin; Italy; Male; Metabolic Syndrome X; M
KW - Medicinal; Silymarin; Time Factors; Treatment Outcome; Weight Loss; Curcuma; Dietary Supplements; Cardiology and Cardiovascular Medicine; Medicine (all)
KW - chlorogenic acid; cholesterol; Curcuma longa; guggul; inulin; metabolic syndrome; natural supplement; oxidative stress; silymarin; Aged; Biomarkers; Blood Glucose; Chlorogenic Acid; Cholesterol; Female; Humans; Inulin; Italy; Male; Metabolic Syndrome X; M
UR - http://hdl.handle.net/10447/197761
UR - http://70.107.241.254/index.htm
M3 - Article
SN - 0003-3197
VL - 66
SP - 856
EP - 861
JO - Angiology
JF - Angiology
ER -